Skip to main content

Provider

By Jessica Hagen | 02:18 pm | February 28, 2024
The company will use the funds to create and launch new products, expand its network and speed up its growth.
HIMSS24
By HIMSS TV | 07:00 am | February 28, 2024
Brenna Loufek, SaMD regulatory affairs manager at Mayo Clinic, discusses her HIMSS24 session on bringing AI-enabled digital health tools built under research into the clinical setting and what she hopes the audience will gain from the discussion.  
By Jessica Hagen | 04:12 pm | February 27, 2024
The company's FHIR-based platform unifies patient's healthcare data to drive personalized care insights.
By HIMSS TV | 12:00 pm | February 27, 2024
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, discusses how Froedtert and Inception Health use genAI, including helping patients with scheduling and navigating healthcare.
By Jessica Hagen | 01:31 pm | February 26, 2024
The investment comes two years after the California-based company secured $65 million in funding.
By HIMSS TV | 12:00 pm | February 26, 2024
Dr. Melek Somai, chief technology and product officer at Froedtert & Medical College of Wisconsin Health Network, relays how genAI is impacting various sectors of healthcare and how harnessing the tech will extend human discovery in medicine.  
By Jessica Hagen | 04:23 pm | February 23, 2024
The company will offer a customizable version of its Marketplace Search Technology to health plans supporting Medicare beneficiaries.
By Jessica Hagen | 03:13 pm | February 23, 2024
Blockchain technology has the potential to transform healthcare, from securing patient data to reducing the risks for data breaches.
HIMSS24
By HIMSS TV | 07:00 am | February 23, 2024
Jim St. Clair of the Interoperability Institute and Dr. Paul Tibbits and Dr. Thomas Osborne of the U.S. Dept. of Veterans Affairs discuss how digital twins are used within federal hospital systems and academic universities to boost care.  
By Adam Ang | 03:35 am | February 23, 2024
Also, Qure.ai has obtained breakthrough device designation for its tuberculosis AI.